Table I.
Patients | Collagen fiber content | α-SMA | CD19 | |||||
---|---|---|---|---|---|---|---|---|
Characteristics | n | % | Mean ± SD | P-value | Mean rank | P-value | Mean rank | P-value |
Age, years | 0.334 | 0.813 | 0.609 | |||||
<50 | 42 | 45.2 | 0.10±0.09 | 47.70 | 44.51 | |||
≥50 | 51 | 54.8 | 0.12±0.10 | 46.42 | 47.22 | |||
Gender | 0.215 | 0.047 | 0.687 | |||||
Male | 56 | 60.2 | 0.13±0.11 | 51.35 | 45.12 | |||
Female | 37 | 39.8 | 0.10±0.09 | 40.42 | 47.28 | |||
Clinical stage | 0.239 | 0.374 | 0.912 | |||||
I–II | 51 | 54.8 | 0.10±0.09 | 43.44 | 44.25 | |||
III–IV | 42 | 45.2 | 0.13±0.10 | 48.19 | 44.83 | |||
Tumor stage | 0.031 | 0.001 | 0.479 | |||||
1–2 | 78 | 85.7 | 0.10±0.10 | 42.34 | 44.27 | |||
3–4 | 13 | 14.3 | 0.17±0.09 | 67.69 | 49.69 | |||
Node stage | 0.966 | 0.209 | 0.207 | |||||
0 | 63 | 69.2 | 0.11±0.11 | 48.23 | 47.22 | |||
1–3 | 28 | 30.8 | 0.11±0.10 | 40.98 | 40.16 | |||
Pathological differentiation | 0.231 | 0.125 | 0.217 | |||||
Well-differentiated | 47 | 50.5 | 0.10±0.09 | 39.80 | 44.64 | |||
Moderately differentiated | 40 | 43.0 | 0.14±0.11 | 52.84 | 46.56 | |||
Poorly differentiated | 6 | 6.5 | 0.10±0.10 | 44.00 | 26.50 | |||
Overall survival | 0.865 | 0.361 | 0.011 | |||||
Alive | 39 | 41.9 | 0.12±0.11 | 30.86 | 35.95 | |||
Succumbed to disease | 25 | 26.9 | 0.11±0.09 | 35.06 | 24.46 | |||
Missing | 29 | 31.2 | 0.11±0.11 |
Collagen fiber content is expressed as a ratio of the percentage of collagen fiber content in the tumor stroma. SMA, smooth muscle actin; CD, cluster of differentiation; SD, standard deviation; Mean rank, the mean as determined by the rank sum test.